This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Pharmacokinetics, Biodistribution, and Toxicity of Folic Acid-Coated Antiretroviral Nanoformulations
- Development and Pre-clinical Evaluation of New 68Ga-NOTA-folate Conjugates for PET Imaging of Folate Receptor-positive Tumors
- Promises of Cyclotron-Produced 44Sc as a Diagnostic Match for Trivalent {beta}--Emitters: In Vitro and In Vivo Study of a 44Sc-DOTA-Folate Conjugate
- 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
- Targeting Folate Receptors to Treat Invasive Urinary Bladder Cancer
- DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted 177Lu-Radionuclide Tumor Therapy in Mice
- A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for {alpha}- and {beta}--Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative
- Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications
- In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with 99mTc-Folate SPECT/CT
- A New 18F-Labeled Folic Acid Derivative with Improved Properties for the PET Imaging of Folate Receptor-Positive Tumors
- Impact of High and Low Folate Diets on Tissue Folate Receptor Levels and Antitumor Responses Toward Folate-Drug Conjugates
- Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue
- Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor-Positive Ovarian Cancer
- SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate
- In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
- Folate Receptor-Specific Antitumor Activity of EC131, a Folate-Maytansinoid Conjugate
- Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
- Effects of Antifolate Drugs on the Cellular Uptake of Radiofolates In Vitro and In Vivo
- Synthesis and Preclinical Evaluation of a Folic Acid Derivative Labeled with 18F for PET Imaging of Folate Receptor-Positive Tumors
- 64Cu-Labeled Folate-Conjugated Shell Cross-Linked Nanoparticles for Tumor Imaging and Radiotherapy: Synthesis, Radiolabeling, and Biologic Evaluation
- Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery
- Antisense oligonucleotides targeted to the human {alpha} folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
- Preclinical Evaluation of 99mTc-EC20 for Imaging Folate Receptor-Positive Tumors
- Evaluation of 111In-DTPA-Folate as a Receptor-Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results
- Expression and Functional Characterization of the beta -Isoform of the Folate Receptor on CD34+ Cells
- Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors {alpha} and {beta}